Natural History of Chronic Hepatitis B Virus Infection: What We Knew in 1981 and What We Know in 2005
Top Cited Papers
- 1 February 2006
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 43 (Supplement), S173-S181
- https://doi.org/10.1002/hep.20956
Abstract
Remarkable progress has been made in our understanding of the natural history of chronic hepatitis B virus (HBV) infection in the past 25 years. Availability of sensitive HBV DNA assays and application of sophisticated immunological techniques led to the recognition that HBV replication persists throughout the course of chronic HBV infection, and host immune response plays a pivotal role in HBV‐related liver disease. Knowledge of the HBV genome organization and replication cycle led to the unraveling of HBV genotypes and molecular variants, which contribute to the heterogeneity in outcome of chronic HBV infection. The natural course of chronic HBV infection is now perceived as consisting of 4 phases: immune tolerance, immune clearance [hepatitis B e antigen (HBeAg)–positive chronic hepatitis], inactive carrier state, and reactivation (HBeAg‐negative chronic hepatitis B). Understanding the dynamic nature of chronic HBV infection is crucial in the management of HBV carriers and underscores the need for long‐term monitoring. Accumulating evidence indicates that antiviral therapy can prevent progression of HBV‐related liver disease, particularly among patients with sustained response. Newer antiviral therapies with improved efficacy and decreased risk of resistance may lead to a complete revision of the chapter on the natural history of chronic HBV infection on the occasion of the golden jubilee of Hepatology . (Hepatology 2006;43:S173–S181.)This publication has 93 references indexed in Scilit:
- Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2005
- Interferon-α for HBeAg-positive chronic hepatitis BJournal of Hepatology, 2003
- Natural History and Prognosis of Hepatitis BSeminars in Liver Disease, 2003
- Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection: Incidence, predisposing factors and etiologyJournal of Hepatology, 1990
- Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis: A clinicopathological studyJournal of Hepatology, 1985
- Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular CarcinomaThe New England Journal of Medicine, 1981
- Hepatitis B virus DNA in the sera of HBsAg carriers: A marker of active hepatitis B virus replication in the liverHepatology, 1981
- Primary hepatocellular carcinoma in alaskan natives, 1969–1979International Journal of Cancer, 1981
- Changes in hepatitis B virus DNA-polymerase activity in patients with chronic infectionJournal of Medical Virology, 1981
- CHRONIC LIVER DISEASE AND PRIMARY LIVER-CELL CANCER WITH HEPATITIS-ASSOCIATED (AUSTRALIA) ANTIGEN IN SERUMThe Lancet, 1970